Blood and plasma treatments: The rationale of high-volume hemofiltration

Contributions to Nephrology

Volumn 156, Issue , 2007, Pages 387-395

  Honoré, Patrick M ^a   Joannes Boyau, Olivier ^b   Gressens, Benjamin ^a  

^a Clinique Saint Pierre of Ottignies   (Belgium)

^b HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; CYTOKINE;

ACUTE KIDNEY FAILURE; ANIMAL; BLOOD; DISEASE MODEL; HEMOFILTRATION; HUMAN; IMMUNOLOGY; INSTRUMENTATION; INTENSIVE CARE; INTENSIVE CARE UNIT; ISOLATION AND PURIFICATION; METHODOLOGY; REVIEW; SEPSIS; SEPTIC SHOCK;

ANIMALS; CRITICAL CARE; CYTOKINES; DISEASE MODELS, ANIMAL; HEMOFILTRATION; HUMANS; INFLAMMATION MEDIATORS; INTENSIVE CARE UNITS; KIDNEY FAILURE, ACUTE; SEPSIS; SHOCK, SEPTIC;

EID: 34247608402     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/0000102129     Document Type: Review

References (30)

1. Damas P, Canivet JL, de Groote D, Vrindts Y, Albert A, Franchimont P, et al: Sepsis and serum cytokines concentrations. Crit Care Med 1997;25:405-412.
2. Casey LC, Balk RA, Bone RC: Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern 1993;119:771-778.
3. Ronco C, Tetta C, Mariano F, Wratten ML, Bonello M, Bellomo R: Interpreting the mechanism of continuous renal replacement therapy in sepsis. The peak concentration hypothesis. Artif Organs 2003;27:792-801.
4. Ronco C, Bellomo R: Acute renal failure and multiple organ dysfunction in the ICU: from renal replacement therapy (RRT) to multiple organ support therapy (MOST). Int J Artif Organs 2002;25:733-747.
5. Ronco C, Ricci Z, Bellomo R: Importance of increased ultrafiltration volume and impact on mortality: sepsis and cytokine story and the role for CVVH. EDTRA ERCA J 2002;2:13-18.
6. Lee PA, Weger G, Pryor RW, Matson JR: Effects of filter pore size on efficacy of continuous arterio-venous haemofiltration therapy for Staphylococcus aureus-induced septicaemia in immature swine. Crit Care Med 1998;26:730-737.
7. Lee WC, Uchino S, Fealy N, Baldwin I, Panagiotopoulos S, Goehl H, Morgera S, Neumayer HH, Bellomo R: Super high flux hemodialysis at high dialysate flows: an ex vivo assessment. Int J Artif Organs 2004;27:24-28.
8. Honoré PM, Matson JR: Hemofiltration, adsorption, sieving and the challenge of sepsis therapy design. Crit Care 2002;6:394-396.
9. Bellomo R, Tetta C, Ronco C: Coupled plasma filtration adsorption. Intensive Care Med 2003;29:1222-1228.
10. Bellomo R, Honoré PM, Matson JR, Ronco C, Winchester J: Extracorporeal blood treatment (EBT) methods in SIRS/Sepsis. Consensus statement. ADQI III Conference. Electronic Supplement Material.www.adqi.net (2005).
11. Honoré PM, Joannes-Boyau O: High volume hemofiltration (HVHF) in sepsis: a comprehensive review of rationale, clinical applicability, potential indications and recommendations for future research. Int J Artif Organs 2004;27:1077-1082.
12. Honoré PM, Matson JR: Extracorporeal removal for sepsis: acting at the tissue level - the beginning of a new era for this treatment modality in septic shock. Crit Care Med 2004;32:896-897.
13. Honoré PM, Jamez J, Wauthier M, Dugernier T: Prospective evaluation of short-time high volume isovolemic hemofiltration on the hemodynamic course and outcome of patients with refractory septic shock. Crit Care Nephrol 1998;90:87-99.
14. Honoré PM, Jamez J, Wittebole X, Wauthier M: Influence of high volume haemofiltration on the haemodynamic course and outcome of patients with refractory septic shock. Retrospective study of 15 consecutives cases. Blood Purif 1997;15:135-136.
15. Klouche K, Cavadore P, Portales P, Clot J, Canaud B, Beraud JJ: Continuous veno-venous hemofiltration improves hemodynamic in septic shock with acute renal failure without modifying TNF-α and IL-6 plasma concentrations. J Nephrol 2002;15:150-157.
16. Di Carlo JV, Alexander SR: Hemofiltration for cytokine-driven illness: the mediator delivery hypothesis. Int J Artif Organs 2005;28:777-786.
17. Olszewski WL: The lymphatic system in body homeostasis: physiological condition lymph fat rest. Lymphat Res Biol 2003;1:11-21.
18. Onarherim H, Missavage E, Gunther RA, Kramer GC, Reed RK, Laurent TC: Marked increase of plasma hyaluronan after major thermal injury and infusion therapy J Surg Res 1991;50:259-265.
19. Wasserman K, Mayerson HS: Dynamics of lymph and plasma protein and exchange. Cardiologia 1952;21:296-307.
20. Rogiers P: High volume haemofiltration: high volume, high permeability: which target (abstract). 4th ERTIC Meeting, Nice, 2005.
21. Honoré PM, Zydney AL, Matson JR: High volume and high permeability haemofiltration in sepsis. The evidence and the key issues. Care Crit Ill 2003;3:69-76.
22. Valbonesi M, Carlier P, Icone A, Accorsi P, Borberg H, Schreiner T, et al: Cascade filtration: a new filter for secondary filtration - a multicentric study. Int J Artif Organs 2004;27:513-515.
23. Matson JR, Zydney RL, Honoré PM: Blood filtration: new opportunities and the implications on system biology. Crit Care Resusc 2004;6:209-218.
24. Bellomo R, Honoré PM, Matson JR, Ronco C, Winchester J: Extracorporeal blood treatment (EBT) methods in SIRS/sepsis. Int J Artif Organs 2005;28:450-458.
25. Honoré PM, Joannes-Boyau O: The IVOIRE study: impact of high volume haemofiltration in early septic shock with acute renal injury: a prospective multicentric randomized study. Presented for the Stoutenbeek Award, 18th Ann Congr ESICM Soc, Berlin, 2004.
26. Joannes-Boyau O, Honoré PM, Boer W, et al: The IVOIRE Study. Description of the methodology and the design used. Submitted to Crit Care 2007.
27. Joannes-Boyau O, Honoré PM, Boer W: Hemofiltration: the case for removal of sepsis mediators from where they do harm. Crit Care Med 2006;34:2244-2246.
28. Honoré PM, Jamez J, Wauthier M, Lee PA, Dugernier Th, Pirenne B, Hanique G, Matson JR: Prospective evaluation of short-term high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 2000;28:3581-3587.
29. Honoré PM, Joannes-Boyau O, Meurson L , Boer W, Piette V, Galloy AC, Janvier G: The big bang of hemofiltration: the beginning of a new era in the third millennium for extra-corporeal blood purification! Int J Artif Organs 2006;29:649-659.
30. Honoré PM, Joannes-Boyau O: The 'French Hemodiafe Trial': this study is neither decisive nor definitive in resolving the controversy on renal replacement therapy in ICU. Int J Artif Organs 2006;29:1190-1192.